Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 Nov;62(5):806–815. doi: 10.1038/bjc.1990.383

Trends in survival for childhood cancer in Britain diagnosed 1971-85.

C A Stiller 1, K J Bunch 1
PMCID: PMC1971530  PMID: 2173943

Abstract

Survival rates were analysed for a population-based series of over 15,000 childhood cancers registered in Great Britain during 1971-85. There were highly significant improvements (P less than 0.001 for trend) in survival for many major diagnostic groups. Between 1971-73 and 1983-85 the actuarial 5-year survival rates increased from 37% to 70% for acute lymphoblastic leukaemia, from 4% to 26% for acute non-lymphoblastic leukaemia, from 76% to 88% for Hodgkin's disease, from 22% to 70% for non-Hodgkin's lymphoma, from 61% to 72% for astrocytoma, from 24% to 42% for medulloblastoma, from 15% to 43% for neuroblastoma, from 58% to 79% for Wilms' tumour, from 17% to 54% for osteosarcoma, from 26% to 61% for rhabdomyosarcoma, from 59% to 94% for malignant testicular germ-cell tumours and from 43% to 77% for malignant ovarian germ-cell tumours. These increases in population-based survival rates reflect the substantial advances in treatment of a wide range of childhood cancers since 1970. The two principal diagnostic groups for which there was no evidence of any trend were retinoblastoma, which already had an excellent prognosis with a 5-year survival rate of over 85%, and Ewing's sarcoma, for which the survival rate remained below 45%.

Full text

PDF
806

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. C., Bloom J., Ertel I., Evans A., Hammond D., Jones H., Levin V., Jenkin D., Sposto R., Wara W. Brain tumors in children: current cooperative and institutional chemotherapy trials in newly diagnosed and recurrent disease. Semin Oncol. 1986 Mar;13(1):110–122. [PubMed] [Google Scholar]
  2. Birch J. M., Marsden H. B. A classification scheme for childhood cancer. Int J Cancer. 1987 Nov 15;40(5):620–624. doi: 10.1002/ijc.2910400508. [DOI] [PubMed] [Google Scholar]
  3. Birch J. M., Marsden H. B., Jones P. H., Pearson D., Blair V. Improvements in survival from childhood cancer: results of a population based survey over 30 years. Br Med J (Clin Res Ed) 1988 May 14;296(6633):1372–1376. doi: 10.1136/bmj.296.6633.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burgers J. M., van Glabbeke M., Busson A., Cohen P., Mazabraud A. R., Abbatucci J. S., Kalifa C., Tubiana M., Lemerle J. S., Voûte P. A. Osteosarcoma of the limbs. Report of the EORTC-SIOP 03 trial 20781 investigating the value of adjuvant treatment with chemotherapy and/or prophylactic lung irradiation. Cancer. 1988 Mar 1;61(5):1024–1031. doi: 10.1002/1097-0142(19880301)61:5<1024::aid-cncr2820610528>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  5. Cangir A., George S., Sullivan M. Unfavorable prognosis of acute leukemia in infancy. Cancer. 1975 Dec;36(6):1973–1978. doi: 10.1002/cncr.2820360907. [DOI] [PubMed] [Google Scholar]
  6. Carlsen N. L., Christensen I. J., Schroeder H., Bro P. V., Erichsen G., Hamborg-Pedersen B., Jensen K. B., Nielsen O. H. Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. A statistical estimate of prognosis based on 253 cases. Cancer. 1986 Dec 15;58(12):2726–2735. doi: 10.1002/1097-0142(19861215)58:12<2726::aid-cncr2820581229>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  7. Craft A. W., Amineddine H. A., Scott J. E., Wagget J. The Northern region Children's malignant disease registry 1968-82: incidence and survival. Br J Cancer. 1987 Dec;56(6):853–858. doi: 10.1038/bjc.1987.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Draper G. J., Sanders B. M., Kingston J. E. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986 May;53(5):661–671. doi: 10.1038/bjc.1986.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Graham-Pole J. Ewing sarcoma: treatment with high dose radiation and adjuvant chemotherapy. Med Pediatr Oncol. 1979;7(1):1–8. doi: 10.1002/mpo.2950070102. [DOI] [PubMed] [Google Scholar]
  10. Gustafsson G., Garwicz S., Hertz H., Johanesson G., Jonmundsson G., Moe P. J., Salmi T., Seip M., Siimes M. A., Yssing M. A population-based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Incidence, patient characteristics and treatment results. Acta Paediatr Scand. 1987 Sep;76(5):781–788. doi: 10.1111/j.1651-2227.1987.tb10565.x. [DOI] [PubMed] [Google Scholar]
  11. Hawkins M. M. Long term survival and cure after childhood cancer. Arch Dis Child. 1989 Jun;64(6):798–807. doi: 10.1136/adc.64.6.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kingston J. E., McElwain T. J., Malpas J. S. Childhood rhabdomyosarcoma: experience of the Children's Solid Tumour Group. Br J Cancer. 1983 Aug;48(2):195–207. doi: 10.1038/bjc.1983.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. La Vecchia C., Morris H. B., Draper G. J. Malignant ovarian tumours in childhood in Britain, 1962-78. Br J Cancer. 1983 Sep;48(3):363–374. doi: 10.1038/bjc.1983.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Leiper A. D., Chessells J. Acute lymphoblastic leukaemia under 2 years. Arch Dis Child. 1986 Oct;61(10):1007–1012. doi: 10.1136/adc.61.10.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lennox E. L., Stiller C. A., Jones P. H., Wilson L. M. Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. Br Med J. 1979 Sep 8;2(6190):567–569. doi: 10.1136/bmj.2.6190.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Makepeace A. R., Maclennan K. A., Hudson G. V., Jelliffe A. M. Hodgkin's disease in childhood: the British National Lymphoma Investigation experience (BNLI Report No 27). Clin Radiol. 1987 Jan;38(1):7–11. doi: 10.1016/s0009-9260(87)80382-3. [DOI] [PubMed] [Google Scholar]
  17. Mann J. R., Pearson D., Barrett A., Raafat F., Barnes J. M., Wallendszus K. R. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer. 1989 May 1;63(9):1657–1667. doi: 10.1002/1097-0142(19900501)63:9<1657::aid-cncr2820630902>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  18. Maurer H. M., Beltangady M., Gehan E. A., Crist W., Hammond D., Hays D. M., Heyn R., Lawrence W., Newton W., Ortega J. The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer. 1988 Jan 15;61(2):209–220. doi: 10.1002/1097-0142(19880115)61:2<209::aid-cncr2820610202>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  19. McWhirter W. R., Stiller C. A., Lennox E. L. Carcinomas in childhood. A registry-based study of incidence and survival. Cancer. 1989 Jun 1;63(11):2242–2246. doi: 10.1002/1097-0142(19890601)63:11<2242::aid-cncr2820631131>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  20. Medeiros L. J., Harris N. L. Lymphoid infiltrates of the orbit and conjunctiva. A morphologic and immunophenotypic study of 99 cases. Am J Surg Pathol. 1989 Jun;13(6):459–471. doi: 10.1097/00000478-198906000-00002. [DOI] [PubMed] [Google Scholar]
  21. Miller D. R., Leikin S., Albo V., Sather H., Karon M., Hammond D. Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from childrens cancer study group. Cancer. 1983 Mar 15;51(6):1041–1049. doi: 10.1002/1097-0142(19830315)51:6<1041::aid-cncr2820510612>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  22. Mott M. G., Chessells J. M., Willoughby M. L., Mann J. R., Morris-Jones P. H., Malpas J. S., Palmer M. K. Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG). Br J Cancer. 1984 Oct;50(4):457–462. doi: 10.1038/bjc.1984.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mott M. G., Eden O. B., Palmer M. K. Adjuvant low dose radiation in childhood non-Hodgkin's lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG). Br J Cancer. 1984 Oct;50(4):463–469. doi: 10.1038/bjc.1984.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Paolucci G., Masera G., Vecchi V., Marsoni S., Pession A., Zurlo M. G. Treating childhood acute lymphoblastic leukaemia (ALL): summary of ten years' experience in Italy. ALL Steering Committee of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Med Pediatr Oncol. 1989;17(2):83–91. doi: 10.1002/mpo.2950170203. [DOI] [PubMed] [Google Scholar]
  25. Pinkerton C. R. Where next with therapy in advanced neuroblastoma? Br J Cancer. 1990 Mar;61(3):351–353. doi: 10.1038/bjc.1990.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Polednak A. P. Recent trends in incidence and mortality rates for leukemias, and in survival rates for childhood acute lymphocytic leukemia, in Upstate New York. Cancer. 1986 May 1;57(9):1850–1858. doi: 10.1002/1097-0142(19860501)57:9<1850::aid-cncr2820570926>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  27. Reaman G. H., Steinherz P. G., Gaynon P. S., Bleyer W. A., Finklestein J. Z., Evans R., Miller D. R., Sather H. N., Hammond G. D. Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Cancer Treat Rep. 1987 Nov;71(11):1033–1038. [PubMed] [Google Scholar]
  28. Robinson B., Kingston J., Nogueira Costa R., Malpas J. S., Barrett A., McElwain T. J. Chemotherapy and irradiation in childhood Hodgkin's disease. Arch Dis Child. 1984 Dec;59(12):1162–1167. doi: 10.1136/adc.59.12.1162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rodary C., Rey A., Rezvani A., Flamant F. Facteurs pronostiques des rhabdomyosarcomes de l'enfant. Etude réalisée sur 253 enfants enregistrés par la Sociéte Internationale d'Oncologie Pédiatrique (SIOP). Bull Cancer. 1988;75(2):213–223. [PubMed] [Google Scholar]
  30. Roper H. P., Essex-Cater A., Marsden H. B., Dixon P. F., Campbell R. H. Nasopharyngeal carcinoma in children. Pediatr Hematol Oncol. 1986;3(2):143–152. doi: 10.3109/08880018609031210. [DOI] [PubMed] [Google Scholar]
  31. Sanders B. M., Draper G. J., Kingston J. E. Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival. Br J Ophthalmol. 1988 Aug;72(8):576–583. doi: 10.1136/bjo.72.8.576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sather H., Coccia P., Nesbit M., Level C., Hammond D. Disappearance of the predictive value of prognostic variables in childhood acute lymphoblastic leukemia: a report from Childrens Cancer Study Group. Cancer. 1981 Jul 15;48(2):370–376. doi: 10.1002/1097-0142(19810715)48:2<370::aid-cncr2820480224>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  33. Steinhorn S. C., Ries L. G. Improved survival among children with acute leukemia in the United States. Biomed Pharmacother. 1988;42(10):675–681. [PubMed] [Google Scholar]
  34. Stiller C. A. Centralisation of treatment and survival rates for cancer. Arch Dis Child. 1988 Jan;63(1):23–30. doi: 10.1136/adc.63.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Stiller C. A., Draper G. J. Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Arch Dis Child. 1989 May;64(5):657–661. doi: 10.1136/adc.64.5.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stiller C. A., Lennox E. L. Childhood medulloblastoma in Britain 1971-77: analysis of treatment and survival. Br J Cancer. 1983 Dec;48(6):835–841. doi: 10.1038/bjc.1983.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Treatment of osteosarcoma. Lancet. 1988 Apr 23;1(8591):931–932. [PubMed] [Google Scholar]
  38. Young J. L., Jr, Ries L. G., Silverberg E., Horm J. W., Miller R. W. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986 Jul 15;58(2 Suppl):598–602. doi: 10.1002/1097-0142(19860715)58:2+<598::aid-cncr2820581332>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES